Gene testing for drugs, Personalized medicine and pharmacogenomics Challenges, Current restrictions on drug labelling Drug Sensitivity and Genetics, Costs and coverage of pharmacogenomics testing Predicting drug-drug interactions is a difficult task. Polypharmacy, Methods based on associations and expressions, Pathway-based techniques and cheminformatics Incorporation of pharmacogenomics into clinical practise Phenotyping and genotyping are two terms that are used interchangeably.
Neurotransmission in the central and peripheral nervous systems, Neurotoxicology, Growth factors for the nerves, cytoskeletal elements of the nervous system, Repairing the brain, Addiction's cellular and molecular mechanisms, Disorders of development and Neurodegeneration interactions between the brain and the immune system.
Clinical pharmacology, such as cardiac pharmacology and cardiovascular disease, pulmonary disease, neurodegenerative disorders, pharmacological oncology, Parkinson's disease, and circadian rhythm disorders, Molecular and Cellular Pharmacology, such as drug-receptor interactions, drug-enzyme interactions, antibiotic pharmacology, and immune responses, gene expression regulation, Pharmacogenetics, Safety Pharmacology, Toxicology, and Pharmacognosy, Environmental Pharmacology
Pharmaceutical Formulations Market, Licensing, Pharma Pricing & Market Access, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic E-pharmaceutical marketing, post-market surveillance, the generic drug industry, contract manufacturing, and health economics, to name a few. Customer Lifetime Valuation, Patient-Centricity, Pharma Segmentation/Localization, Predictive Analytics, Pre-clinical Discovery, Commercial Models, Customer Lifetime Valuation, Patient-Centricity Statistical Approaches for Improving Performance and Compliance with Big Data, Architecture, Informatics, and Big Data.
Data-Driven Health and Personalization, the Role of Artificial Intelligence in the Pharmaceutical Industry, Digital transformation on a global scale, calculating digital ROI, and analyzing digital analytics. It is critical to align innovation with company objectives. Customer Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation, A True Learning Plan's Metrics, Marketing in a Multichannel World, Multichannel Engagement Mobilizing for Mobile Engagement, Customer Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation, A True Learning Plan's Metrics
Pharmaceutical microbiology and animal biotechnology have evolved as a useful field for the productions of biologics from microbial cells or animal or human cell lines. Biotechnological concepts and manipulations in the these filed has enhanced the production, variety and types of biologics produced. These field are expected to grow further in the future.
Pharmaceutical and medical chemistry are interdisciplinary scientific topics that deal with drug development, molecular mechanisms of pathogenesis, pharmaceutics, pharmacology, toxicology, organic chemistry, and more. Individual investigations in both disciplines provide improved insights and understanding for the creation of novel medications and therapies.
In the field of pharmaceutical biotechnology, recent developments have been made. Recombinant DNA Technology: Basic Techniques and Tools, Vectors, Cloning Strategies, and Host Systems Genetic engineering has been used to make recombinant therapeutic proteins, vaccines, recombinant blood products and therapeutic enzymes, as well as nucleic acid and cell-based medicines.
Pharmaceutical nanotechnology provides innovative tools and technology, as well as opportunities and scope, in many areas of the healthcare industry, and it is now well-established as a specialised area for drug delivery, diagnostics, prognostics, and various treatment procedures, thanks to its nano-engineered tools and techniques. By overcoming the constraints of present technology in the pharmaceutical sector, it will have a significant impact in the future.
In the field of drug regulation, pharmacovigilance is a term that is used to describe the monitoring of Trials in Medicine, Clinical safety prior to marketing, Safety of drugs once they've been released, Strategies for risk management, Data mining and signal detection Drug interaction detection, Harmonization of drug regulatory requirements on a global scale, Management of risks and crises Traditional and Herbal Medicines, Vaccines and biological medicines are two examples of vaccines.
Spectroscopic Techniques, Mass Spectrometry in Bioanalysis, Mass Spectrometry Method Development and Validation, HPLC Method Development and Validation, Analytical Techniques, Mass Spectrometry Method Development and Validation Qualitative Analytical Techniques, Qualitative Analysis, Advances in Sample Preparation for Bioanalytical Techniques
Cosmetics' Function, Cosmetics' biological impacts, a framework for regulation How do cosmetics vary from pharmaceuticals? Product Evaluation, Cosmetics and Microbiological Safety, Hair and Skin Care, Packaging, efficacy and safety Processes for anti-aging and tissue repair Biotech product development opportunities and challenges Cosmetics and the marketplace, the interface and interaction between food and cosmetics, Animal Experiments, Microbeads made of plastic, Endocrine disruptors, endocrine disruptors, endocrine disruptor Products that are fakes
General practitioners require medical emergency knowledge, skills, medications, and equipment. Clinics require treatment rooms and doctor's packs to tackle onsite and offsite emergencies, respectively. In their local hospitals, rural medical generalists may provide more advanced emergency management. GPs may collaborate with paramedics in emergency situations, therefore familiarity with their expertise and the drugs they carry is beneficial.
The most often utilized drug delivery systems are the oral and parenteral drug administration systems. Alternative drug delivery mechanisms such as pulmonary drug delivery, transdermal drug delivery, prodrug delivery, ocular drug delivery, and transmucosal drug delivery will be discussed in this session.
To tackle the problems of drug delivery, new technologies and methodologies are being developed. Smart drug delivery systems, sustained release drug delivery systems, nano particle-based drug delivery systems, medical devices for drug delivery, biologics drug delivery systems, and printing technology in dosage forms are among them. Drug delivery systems (DDS) are a group of novel methodologies that combine pharmaceutics, bio conjugate chemistry, molecular biology, pharmacology, polymer sciences, nanotechnology, and electronics in a multidisciplinary approach. A successful drug delivery system is essential for effective disease therapy.
This session addresses important issues in drug delivery systems such as poorly soluble drug component distribution and bioavailability, as well as drug molecules' inaccessibility to the target location. Biologics (peptides, proteins, and DNA-based therapies) drug delivery, as well as pediatric and geriatric medication delivery, are all major challenges. Despite the fact that various tactics and procedures have been created to address drug delivery issues, they have some flaws. Such barriers in drug delivery systems can be overcome with the help of innovative technology.
Recent advancements in research, Clinical trials, patient-centered clinical trial techniques, Preclinical Research Innovations, Medical Imaging, Clinical Trial Participation Multi-arm multi-stage (MAMS) trials, Pharmacodynamics, Screening, Ethical aspects, Patient safety, International Regulatory Affairs, Quality assurance, Biosimilars Licensing and authorization are required. Regulatory Affairs, Regulatory and Post-Marketing Issues: International Guidelines
Drug discovery and development in its entirety, encompassing genomics and proteomics research, applications, technologies, and tactics to speed up the pace and productivity of drug development. Pharmacotherapy, Clinical trials, Case studies in a variety of therapeutic and disease domains, translational medicine, translational and preclinical models
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by